Physician profile
Michael Mackenzie Johnson
NPI 1609869643
$10,214.21
in general payments reported to CMS, 2019-2025
60 companies · $1,856 in 2025
The $1,856 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2020: $939 · 2021: $1,726 · 2022: $1,891 · 2023: $1,359 · 2024: $1,119 · 2025: $1,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,333.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,077.42 | 2019-2025 | Repatha, Evenity, Otezla |
| Astrazeneca Pharmaceuticals LP | $916.09 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $660.40 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Pfizer INC. | $618.25 | 2019-2025 | |
| Glaxosmithkline, LLC. | $603.89 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $590.09 | 2019-2025 | Jot Dx, Freestyle Libre 2, Octrode |
| Abbvie INC. | $542.19 | 2019-2024 | |
| Astellas Pharma US INC | $474.35 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $462.96 | 2023-2025 | Gemtesa |
| Novo Nordisk INC | $423.98 | 2019-2025 | Rybelsus, Ozempic |
| Amarin Pharma, INC. | $369.68 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $324.22 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $282.15 | 2019-2025 | Jardiance, Mounjaro, Kisunla |
| Merck Sharp & Dohme LLC | $252.86 | 2019-2025 | Capvaxive, Gardasil 9 |
| Sunovion Pharmaceuticals INC. | $247.71 | 2019-2022 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $239.30 | 2019-2024 | |
| Nestle Healthcare Nutrition INC. | $180.41 | 2021-2023 | |
| Edwards Lifesciences Corporation | $156.29 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $150.71 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $115.06 | 2019-2023 | |
| Radius Health, INC. | $113.97 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $111.76 | 2019-2022 | |
| Lucid Diagnostics INC. | $83.19 | 2021-2023 | |
| Corcept Therapeutics | $80.11 | 2025 | Korlym |
| Medtronic, INC. | $78.93 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $75.52 | 2022-2023 | |
| Philips North America LLC | $56.89 | 2019-2020 | |
| Abiomed | $53.66 | 2023 | Impella |
| Kowa Pharmaceuticals America, INC. | $50.81 | 2022 | |
| Scilex Pharmaceuticals INC. | $49.46 | 2023-2024 | Ztlido |
| Phathom Pharmaceuticals, INC. | $49.22 | 2024-2025 | Voquezna |
| Xeris Pharmaceuticals, INC. | $46.72 | 2023-2024 | Keveyis, Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $45.85 | 2021 | |
| Dexcom, INC. | $45.74 | 2025 | Dexcom G6 Transmitter |
| Biotronik Nro, INC. | $42.52 | 2023-2024 | Biotronik, Prospera |
| Nalu Medical, INC. | $40.23 | 2021-2022 | |
| Exact Sciences Corporation | $39.52 | 2023-2024 | Cologuard Collection Kit |
| Nevro Corp. | $33.77 | 2023 | Senza |
| Alphatec Spine, INC | $31.53 | 2021 | |
| Eisai INC. | $27.22 | 2024 | |
| Inspire Medical Systems, INC. | $24.73 | 2023 | Inspire |
| Cmp Pharma, INC. | $24.08 | 2024 | Norliqva, Liqrev, Atorvaliq |
| Ethicon US, LLC | $23.47 | 2022 | |
| Depuy Synthes Sales INC. | $23.36 | 2019 | |
| Aimmune Therapeutics, INC. | $22.69 | 2025 | Zenpep |
| Alfasigma USA, INC. | $22.63 | 2020 | |
| Organogenesis INC. | $21.89 | 2025 | Puraply Wound Matrix |
| Inogen, INC. | $20.26 | 2025 | |
| Paratek Pharmaceuticals, INC. | $19.84 | 2023 | Nuzyra |
| Tanabe Pharma America, INC. | $17.94 | 2023 | |
| Painteq LLC | $17.25 | 2024 | Painteq |
| Axonics, INC. | $15.87 | 2024 | Axonics |
| Sanofi Pasteur INC. | $15.62 | 2021 | |
| Impulse Dynamics (USA) INC. | $15.59 | 2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.57 | 2022 | |
| Strongbridge US INC. | $15.50 | 2019 | |
| Esperion Therapeutics, INC. | $14.99 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.98 | 2022 | |
| Smith+Nephew, INC. | $12.77 | 2023 | Redapt, Journey II |
| Apria Healthcare LLC | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.